Annette Matthies
Corporate Officer/Principal presso Elicio Therapeutics, Inc. (Old)
Provenienza dei contatti di primo grado di Annette Matthies
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.
20
| Subsidiary | Biotechnology | 20 |
12
| Subsidiary | Pharmaceuticals: Major | 12 |
| Public Company | Biotechnology | 8 | |
Abbott Laboratories, Inc.
 Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL.
2
| Subsidiary | Medical Specialties | 2 |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Annette Matthies tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | President Chief Executive Officer Chief Executive Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Florida | College/University | Undergraduate Degree Doctorate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Director/Board Member Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Masters Business Admin | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor Chief Executive Officer Private Equity Investor | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Tech/Sci/R&D Officer | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Chairman Director/Board Member | |
| METACRINE, INC. | Biotechnology | Director/Board Member Founder | |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Investment Managers | Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| CLAL Application Center Ltd. | Chairman Director/Board Member | ||
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Chairman | |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Polyheal Ltd.
 Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder | |
Jewish Federation of Omaha, Inc.
 Jewish Federation of Omaha, Inc. Miscellaneous Commercial ServicesCommercial Services Jewish Federation of Omaha, Inc. offers social, educational and cultural programs through fundraising. It supports communal services in the Omaha area by establishing and accumulating assets for permanent funding resources. The company was founded in 1903 and is headquartered in Omaha, NE. | Miscellaneous Commercial Services | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 36 |
| Israele | 12 |
| Danimarca | 2 |
| Regno Unito | 2 |
| Canada | 2 |
Settori
| Health Technology | 36 |
| Finance | 7 |
| Consumer Services | 6 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 286 |
| Corporate Officer/Principal | 100 |
| Independent Dir/Board Member | 92 |
| Chief Executive Officer | 41 |
| Undergraduate Degree | 37 |
Contatti più connessi
| Insiders | |
|---|---|
| Amir Nashat | 49 |
| Douglas Cole | 44 |
| Richard Heyman | 33 |
| Karen Wilson | 31 |
| Ofer Gonen | 31 |
| Jay Venkatesan | 30 |
| Maha Katabi | 28 |
| Mary Lynne Hedley | 25 |
| Robert Ruffolo | 24 |
| Julian Adams | 23 |
| John Smither | 20 |
| Assaf Segal | 19 |
| Mary Szela | 19 |
| Allen Nissenson | 17 |
| Robert Connelly | 15 |
- Borsa valori
- Insiders
- Annette Matthies
- Connessioni Società
